This episode of Deep Dive takes you inside one of the most complex and fast-evolving areas of modern medicine—lung cancer. Whether you’re newly diagnosed, supporting someone who is, or simply seeking reliable information, this conversation delivers clarity and hope.
You’ll learn:
- The key differences between non-small cell (NSCLC) and small cell lung cancer (SCLC)
- Why early symptoms are so often missed—and what to watch for
- How staging works and what TNM really means for treatment
- Advances in precision medicine: EGFR, ROS1, KRAS G12D, HER2-targeted therapies
- The growing power of immunotherapy and antibody-drug conjugates
- Why early palliative care isn’t just supportive—but potentially life-extending
- The latest in screening guidelines and why small cell cancer demands prevention
- New hope even in aggressive or extensive-stage disease with chemo-immunotherapy
Sponsored by StoneFly, your go-to for scalable storage, backup, cloud, and cybersecurity infrastructure. Learn more at stonefly.com.
Whether you’re navigating lung cancer personally or professionally, this episode is packed with essential insights and real-world takeaways to help you make informed, empowered decisions. Tune in—and take the first step toward clarity and confidence.
